You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Details for Patent: 9,375,410


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,375,410
Title:Modified release dosage forms of skeletal muscle relaxants
Abstract: A unit dosage form, such as a capsule or the like, for delivering a skeletal muscle relaxant, such as cyclobenzaprine hydrochloride, into the body in an extended or sustained release fashion comprising one or more populations of drug-containing particles (beads, pellets, granules, etc.) is disclosed. At least one bead population exhibits a pre-designed sustained release profile. Such a drug delivery system is designed for once-daily oral administration to maintain an adequate plasma concentration-time profile, thereby providing relief of muscle spasm associated with painful musculoskeletal conditions over a 24 hour period.
Inventor(s): Venkatesh; Gopi M. (Vandalia, OH), Clevenger; James M. (Vandalia, OH)
Assignee: ADARE PHARMACEUTICALS, INC. (Lawrenceville, NJ)
Application Number:14/496,890
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,375,410
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,375,410

To delve into the specifics of the United States Patent 9,375,410, it is crucial to analyze its scope, claims, and the broader patent landscape it operates within. Here is a detailed breakdown of these aspects.

Patent Overview

United States Patent 9,375,410, like any other patent, is a grant of rights for an invention, issued by the U.S. Patent and Trademark Office (USPTO)[2].

Invention and Inventorship

The patent is awarded to the true and only inventors who conceived the idea and reduced it to practice. Correct inventorship is critical, as errors or deceptive intent can render the patent unenforceable[5].

Patent Claims

Patent claims define the scope of the invention and are crucial for determining what is protected by the patent. These claims must be clear, concise, and definite to avoid ambiguity and potential legal challenges.

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.

Claim Analysis

For a patent like 9,375,410, each claim must be analyzed to understand its scope and how it contributes to the overall protection of the invention. This involves examining the language and elements of each claim to determine what is novel and non-obvious.

Subject Matter Eligibility

The USPTO's recent guidance updates, such as those from 2024, emphasize the importance of subject matter eligibility, particularly for AI-related inventions. Claims must integrate judicial exceptions into practical applications to be considered patent-eligible. For example, claims that merely use abstract ideas or mathematical models without a practical application are generally not eligible[1].

Practical Application

To meet the criteria for patent eligibility, claims must demonstrate a practical application that provides concrete benefits or solves specific problems in the relevant field. This is illustrated by examples provided in the USPTO guidance, where specifying the use of AI in a real-world application, such as enhancing speech recognition accuracy, makes the claim patent-eligible[1].

Recent Case Law and Guidance

The USPTO integrates recent Federal Circuit decisions into its guidance, ensuring that the application of patent eligibility criteria is consistent and up-to-date. This helps practitioners draft claims that are more likely to avoid section 101 rejections[1].

AI-Assisted Inventions

The 2024 USPTO guidance clarifies that the use of AI in the development of an invention does not impact its subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies[1].

Patent Landscape

The patent landscape includes all existing patents, published patent applications, and other related intellectual property. Tools like the USPTO's Global Dossier and Public Search Facility help in navigating this landscape by providing access to file histories, patent families, and other relevant data[4].

Global Dossier

This service allows users to view the file histories of related applications from participating IP Offices, which is useful for understanding the global context of a patent like 9,375,410[4].

Public Search Facility

Located in Alexandria, VA, this facility provides public access to patent and trademark information, assisting in thorough searches and analyses of existing patents and applications[4].

Economic and Research Implications

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents and applications, which can be used to analyze trends and scope measurements. This dataset is valuable for understanding the broader economic and research implications of patents like 9,375,410[3].

Examples and Case Studies

Analyzing specific examples, such as those provided in the USPTO guidance (e.g., Examples 47-49), can help in understanding how claims in various fields can be crafted to meet patent eligibility criteria. These examples illustrate how integrating abstract ideas into practical applications can make claims patent-eligible[1].

Real-World Applications

Highlighting the real-world applications of the claimed method or system is crucial for demonstrating patent eligibility. For instance, if a claim specifies the use of an AI algorithm in a speech recognition system to improve accuracy, it shows a tangible benefit and practical utility, which are key factors in determining patent eligibility[1].

Key Takeaways

  • Subject Matter Eligibility: Claims must integrate judicial exceptions into practical applications to be patent-eligible.
  • Practical Application: Specifying the use of the invention in a real-world context is essential for demonstrating patent eligibility.
  • AI-Assisted Inventions: The use of AI in invention development does not affect subject matter eligibility.
  • Recent Case Law: The USPTO guidance incorporates recent Federal Circuit decisions to ensure consistency in patent eligibility criteria.
  • Patent Landscape: Understanding the global and domestic patent landscape is crucial for navigating intellectual property rights.

FAQs

What is the significance of subject matter eligibility in patent claims?

Subject matter eligibility is crucial as it determines whether a claim integrates a judicial exception into a practical application, making it patent-eligible.

How does the use of AI impact patent eligibility?

The use of AI in the development of an invention does not impact its subject matter eligibility; the focus remains on the claimed invention itself.

What role do recent Federal Circuit decisions play in patent guidance?

Recent Federal Circuit decisions are integrated into the USPTO guidance to ensure consistency and clarity in the application of patent eligibility criteria.

How can real-world applications influence patent eligibility?

Specifying the real-world application of a claimed method or system can demonstrate practical utility and tangible benefits, making the claim more likely to be patent-eligible.

What tools are available for navigating the patent landscape?

Tools such as the USPTO's Global Dossier and Public Search Facility provide access to file histories, patent families, and other relevant data to help navigate the patent landscape.

Cited Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz.
  2. U.S. Patent and Trademark Office (USPTO) | USAGov - USA.gov.
  3. Patent Claims Research Dataset - USPTO - USPTO.
  4. Search for patents - USPTO - USPTO.
  5. Determining Inventorship for US Patent Applications - Oregon State University.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,375,410

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,375,410

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
World Intellectual Property Organization (WIPO) 2005048996 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.